INDICATIONS
Mast Ext 200 is a slow released long acting treatment for breast cancer in elderly post menopausel women as part of a specific immunotherapy.
INGREDIENT
Drostalone Enanthate 200mg
PRESENTATION
Each vial contains 10ml (200mg/ml)
INDICATIONS
Mast Ext 200 is a slow released long acting treatment for breast cancer in elderly post menopausel women as part of a specific immunotherapy.
INGREDIENT
Drostalone Enanthate 200mg
PRESENTATION
Each vial contains 10ml (200mg/ml)
Other Products